Ufp Technologies (UFPT) Change in Accured Expenses (2010 - 2026)
Ufp Technologies (UFPT) posted Change in Accured Expenses of -$2.5 million for Q1 2026, down 263.07% on a QoQ basis from -$696000.0 in Q4 2025, and up 14.05% year-over-year from -$2.2 million in Q1 2025.
Ufp Technologies (UFPT) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Ufp Technologies' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$2.5 million for Q1 2026.
- Quarterly Change in Accured Expenses rose 14.05% year-over-year to -$2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.3 million (down 37.18% YoY) and the FY2025 annual result came in at -$5.7 million, up 12.23% from the prior year.
- Change in Accured Expenses was -$2.5 million for Q1 2026 at Ufp Technologies, down from -$696000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $8.0 million in Q2 2022 and bottomed at -$11.3 million in Q3 2022.
- A 5-year average of -$1.1 million and a median of -$1.1 million in 2024 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 1779.75% in 2022, while the deepest fall reached 1937.85% in 2022.
- Ufp Technologies' Change in Accured Expenses stood at $3.4 million in 2022, then sank by 142.92% to -$1.4 million in 2023, then gained by 22.25% to -$1.1 million in 2024, then surged by 38.13% to -$696000.0 in 2025, then slumped by 263.07% to -$2.5 million in 2026.
- Business Quant data shows UFPT's Change in Accured Expenses at -$2.5 million in Q1 2026, -$696000.0 in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.82 Bn | 176.53 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.59 Bn | 67.14 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 28.11 Bn | 25.82 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.28 Bn | 21.15 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Ufp Technologies | 1.91 Bn | 1.89 Bn | 44.36 Mn | -2.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.53 Mn |
| Mar 31, 2026 | -2.53 Mn |
| Dec 31, 2025 | -696,000.00 |
| Dec 31, 2025 | -696,000.00 |
| Sep 30, 2025 | 2.05 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | -4.15 Mn |
| Jun 30, 2025 | -4.15 Mn |
| Mar 31, 2025 | -2.94 Mn |
| Mar 31, 2025 | -2.94 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Sep 30, 2024 | -3.36 Mn |
| Sep 30, 2024 | -3.36 Mn |
| Jun 30, 2024 | 3.54 Mn |
| Jun 30, 2024 | 3.54 Mn |
| Mar 31, 2024 | -5.60 Mn |
| Mar 31, 2024 | -5.60 Mn |
| Dec 31, 2023 | -1.45 Mn |
| Dec 31, 2023 | -1.45 Mn |